Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net deposit increase | 363.30%26.66B | 328.00%15.75B | 27.44%8.64B | 143.31%6.58B | --5.75B | --3.68B | --6.78B | -90.97%2.7B | --0 | ---- |
| Net increase in borrowings from central bank | 2,587.81%2.11B | ---- | -73.31%13.88M | -77.73%720.07M | --78.66M | --67.65M | --52M | --3.23B | ---- | ---- |
| Cash received from interests, fees and commissions | -7.43%7.26B | -7.12%4.96B | -13.67%2.26B | -2.04%10.68B | -3.43%7.84B | -2.22%5.34B | 3.31%2.61B | 5.08%10.91B | 1.47%8.12B | 1.35%5.46B |
| Net increase in repurchase business capital | ---- | --2.49B | ---- | ---- | ---- | ---- | --1.6B | --2.4B | ---- | ---- |
| Net increase in funds disbursed | 482.78%8.39B | --6.4B | -38.67%1.23B | ---- | -11.65%1.44B | ---- | 806.46%2B | -65.46%2.51B | -76.19%1.63B | -53.23%1.75B |
| Cash received relating to other operating activities | -17.53%1.42B | -94.15%182.64M | -91.04%226.29M | 51.28%655.74M | 217.54%1.72B | 74.99%3.12B | 1,778.31%2.53B | 114.92%433.47M | 581.77%541.7M | 4,248.55%1.78B |
| Adjustment items of operating cash inflws | 0.00%-1K | ---- | ---1K | ---- | ---1K | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | 111.29%46.38B | 94.42%29.78B | -36.26%12.39B | -2.31%25.86B | 51.20%21.95B | 19.34%15.32B | 451.38%19.44B | -60.67%26.48B | -69.87%14.52B | -73.62%12.84B |
| Staff behalf paid | -1.40%1.08B | -2.88%772.77M | -5.65%499.82M | 0.07%1.39B | 0.46%1.09B | 0.40%795.65M | 2.00%529.76M | 10.53%1.39B | 11.79%1.09B | 14.92%792.5M |
| All taxes paid | 8.09%515.86M | 11.60%364.72M | 30.47%187.47M | -8.30%689.05M | -17.01%477.25M | -20.07%326.82M | 37.63%143.69M | -8.47%751.38M | -22.94%575.05M | -16.20%408.89M |
| Net loan and advance increase | --29.68B | 273.16%15.85B | 487.98%5.22B | ---- | ---- | 185.91%4.25B | -60.39%887.9M | -61.01%10.13B | -79.87%3.14B | -85.16%1.49B |
| Net deposit in central bank and institutions | ---- | --972.02M | --1.92B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net lend capital | 211.57%7.05B | 1,610.99%4.56B | -16.62%841.84M | -46.44%2.85B | -50.19%2.26B | -92.91%266.37M | -59.85%1.01B | -11.02%5.32B | 1.68%4.55B | 39.30%3.76B |
| Cash paid for fees and commissions | 3.07%4.02B | -9.65%2.6B | -19.84%964.83M | 2.70%5.2B | 3.66%3.9B | 8.61%2.88B | 11.56%1.2B | -3.94%5.06B | -2.88%3.77B | 2.27%2.65B |
| Net increase in financial assets held for trading purposes | -41.40%2.35B | --4.47B | ---- | 1,086.08%11.39B | 108.76%4.01B | ---- | -69.89%994.99M | --960.58M | --1.92B | ---- |
| Cash paid relating to other operating activities | -40.95%850.83M | -82.85%604.85M | -96.07%113.12M | 88.94%1.35B | -35.68%1.44B | 276.79%3.53B | 458.18%2.88B | -30.35%715.21M | 165.56%2.24B | -33.58%936.15M |
| Adjustment items of operating cash outflws | 100.00%2K | ---- | ---1K | ---- | 0.00%1K | ---- | ---- | ---- | --1K | ---- |
| Cash outflows from operating activities | 189.73%50.13B | 109.52%31.93B | -50.22%10.77B | -2.17%30.18B | -50.58%17.3B | -62.16%15.24B | -10.36%21.63B | -24.79%30.85B | 3.47%35.01B | 29.14%40.27B |
| Adjustment items of net operating cash flow | --1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash flows from operating activities | -180.58%-3.75B | -2,735.47%-2.14B | 173.95%1.62B | 1.30%-4.32B | 122.70%4.65B | 100.30%81.34M | 89.36%-2.19B | -116.63%-4.37B | -242.78%-20.49B | -256.94%-27.43B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 137.04%76.95B | 112.84%55.26B | 110.37%25.23B | -26.04%45.91B | -21.71%32.46B | -16.03%25.96B | 87.10%11.99B | -87.93%62.08B | -89.54%41.46B | -86.74%30.92B |
| Cash received from returns on investments | -12.10%1.32B | -36.43%414.11M | -12.13%630.27M | 16.58%2.42B | 29.51%1.5B | 48.08%651.41M | 112.09%717.24M | -19.70%2.08B | -25.72%1.16B | -20.77%439.9M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 11,674.03%63.93M | 3,060.94%9.12M | 4,960.16%12.45M | -98.43%714.53K | -98.42%543K | -97.96%288.51K | -96.50%246K | -40.97%45.6M | 55.21%34.43M | 92.26%14.12M |
| Cash inflows from investing activities | 130.63%78.33B | 109.22%55.69B | 103.56%25.87B | -24.71%48.34B | -20.38%33.96B | -15.16%26.62B | 88.16%12.71B | -87.58%64.2B | -89.29%42.66B | -86.57%31.37B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 27.25%237.86M | 78.80%173.56M | 111.98%51.06M | -7.74%313.8M | -29.41%186.93M | -39.54%97.07M | -62.02%24.09M | -38.19%340.11M | -29.85%264.82M | -17.30%160.56M |
| Cash paid to acquire investments | 91.21%75.81B | 76.42%53.6B | 67.07%22.94B | -15.37%62.35B | -22.13%39.65B | -6.79%30.38B | -7.09%13.73B | -86.00%73.67B | -87.49%50.92B | -86.53%32.6B |
| Cash outflows from investing activities | 90.91%76.05B | 76.42%53.77B | 67.15%23B | -15.33%62.66B | -22.17%39.84B | -6.96%30.48B | -7.32%13.76B | -85.95%74.01B | -87.44%51.18B | -86.48%32.76B |
| Adjustment items of net investing cash flow | ---- | ---- | ---- | ---- | ---- | ---- | --1K | ---- | ---1K | ---- |
| Net cash flows from investing activities | 138.84%2.28B | 149.59%1.92B | 375.08%2.88B | -46.06%-14.32B | 31.14%-5.87B | -179.24%-3.86B | 87.06%-1.05B | -0.18%-9.81B | 9.07%-8.53B | 83.84%-1.38B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.5B | --3.5B | ---- |
| Cash from bonds issue | -0.43%60.48B | -5.11%38.93B | -24.24%16.19B | -7.70%78.75B | -17.24%60.75B | -8.93%41.03B | -15.33%21.37B | -33.94%85.32B | -24.65%73.4B | -36.68%45.05B |
| Adjustment items of financing cash inflows | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1K | ---- |
| Cash inflows from financing activities | -0.43%60.48B | -5.11%38.93B | -24.24%16.19B | -11.34%78.75B | -21.01%60.75B | -8.93%41.03B | -15.33%21.37B | -31.23%88.82B | -21.06%76.9B | -36.68%45.05B |
| Borrowing repayment | 7.52%60.52B | -6.11%36.4B | -1.49%19.19B | -13.02%67.56B | -0.21%56.29B | 1.49%38.77B | 1.14%19.48B | -38.93%77.67B | -39.53%56.41B | -48.56%38.2B |
| Dividend interest payment | -20.79%1.1B | -38.04%576.04M | -2.33%72.76M | 61.13%2.05B | 33.52%1.39B | 8.69%929.77M | 0.37%74.49M | -4.58%1.27B | 1.00%1.04B | -12.58%855.39M |
| -Including:Cash payments for dividends or profit to minority shareholders | -25.00%16.34M | ---- | ---- | --21.78M | --21.78M | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | -50.96%1.74M | 44.30%810K | ---- | ---- | --3.55M | --561.32K | ---- | ---- | ---- | ---- |
| Special items of financing cash outflows | -0.80%93.86M | -21.44%63.67M | -16.49%26.23M | 3.35%153.94M | 0.78%94.63M | 23.27%81.05M | 13.18%31.41M | 27.30%148.95M | 8.83%93.9M | -65.80%65.75M |
| Adjustment items of financing cash outflows | 0.00%1K | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from financing activities | 6.82%61.72B | -6.89%37.04B | -1.52%19.29B | -11.79%69.77B | 0.41%57.78B | 1.69%39.78B | 1.16%19.59B | -38.51%79.09B | -39.04%57.55B | -48.14%39.12B |
| Adjustment items of net financing cash flow | --1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash flows from financing activities | -141.93%-1.24B | 51.83%1.89B | -273.61%-3.1B | -7.63%8.99B | -84.69%2.96B | -78.99%1.25B | -69.65%1.78B | 1,730.45%9.73B | 542.74%19.35B | 238.31%5.93B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 22.89%-8.13M | -133.09%-1.12M | -78.46%2.27M | -39.91%11M | -128.34%-10.54M | -93.42%3.38M | 142.99%10.52M | -89.81%18.31M | -77.58%37.21M | -41.19%51.42M |
| Adjustment items effecting cash and cash equivalents | ---2K | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | -200.00%-1K | ---- |
| Net increase in cash and cash equivalents | -256.95%-2.72B | 165.63%1.66B | 197.24%1.4B | -117.56%-9.64B | 117.98%1.73B | 88.91%-2.53B | 93.68%-1.44B | -125.74%-4.43B | -218.15%-9.63B | -583.96%-22.83B |
| Add:Begin period cash and cash equivalents | -34.94%17.96B | -34.94%17.96B | -34.94%17.96B | -13.84%27.6B | -13.84%27.6B | -13.84%27.6B | -13.84%27.6B | 116.25%32.03B | 116.25%32.03B | 116.25%32.03B |
| Adjustment items for cash and cash equivalent increase | ---- | ---- | ---- | ---- | 0.00%1K | ---- | ---- | ---- | --1K | ---- |
| End period cash equivalent | -48.04%15.24B | -21.74%19.62B | -25.98%19.36B | -34.94%17.96B | 30.92%29.33B | 172.59%25.06B | 184.55%26.15B | -13.84%27.6B | -2.42%22.4B | -52.92%9.2B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.